Aerie Pharmaceuticals Investor Day 2016

Aerie Pharmaceuticals held an investor day on October 5, 2016, featuring presentations on company strategy, clinical updates for Roclatan and Rhopressa ophthalmic solutions, market opportunity, and pipeline developments. The agenda included sessions with executives covering physician perspectives, global strategy, financial summary, and Q&A discussions.